Analysis of the Potential Relationship between Aging and Pulmonary Fibrosis Based on Transcriptome

Idiopathic pulmonary fibrosis (IPF) is an age-related interstitial lung disease with a high incidence in the elderly. Although many reports have shown that senescence can initiate pulmonary fibrosis, the relationship between aging and pulmonary fibrosis has not been explained systematically. In our study, young and old rats were intratracheally instilled with bleomycin (1 mg/kg), and the basic pathological indexes were determined using a commercial kit, hematoxylin, and eosin (H&E) and Masson’s Trichrome staining, immunohistochemistry, immunohistofluorescence, and q-PCR. Then, the lung tissues of rats were sequenced by next-generation sequencing for transcriptome analysis. Bioinformatics was performed to analyze the possible differences in the mechanism of pulmonary fibrosis between aged and young rats. Finally, the related cytokines were determined by q-PCR and ELISA. The results indicate that pulmonary fibrosis in old rats is more serious than that in young rats under the same conditions. Additionally, transcriptomic and bioinformatics analysis with experimental validation indicate that the differences in pulmonary fibrosis between old and young rats are mainly related to the differential expression of cytokines, extracellular matrix (ECM), and other important signaling pathways. In conclusion, aging mainly affects pulmonary fibrosis through the ECM–receptor interaction, immune response, and chemokines.

[1]  Xinyang Hu,et al.  FMO2 (Flavin Containing Monooxygenase 2) Prevents Cardiac Fibrosis via CYP2J3-SMURF2 Axis , 2022, Circulation research.

[2]  C. Pabelick,et al.  Cellular Senescence in Aging Lungs and Diseases , 2022, Cells.

[3]  Kakuhiro Yamaguchi,et al.  Association of the RAGE/RAGE-ligand axis with interstitial lung disease and its acute exacerbation. , 2022, Respiratory investigation.

[4]  P. Kordowitzki,et al.  Chromosome Segregation in the Oocyte: What Goes Wrong during Aging , 2022, International journal of molecular sciences.

[5]  Qiaojun He,et al.  Targeting PI3K/AKT signaling for treatment of idiopathic pulmonary fibrosis , 2021, Acta pharmaceutica Sinica. B.

[6]  W. Kim,et al.  Reduced receptor for advanced glycation end products is associated with α-SMA expression in patients with idiopathic pulmonary fibrosis and mice , 2021, Laboratory Animal Research.

[7]  N. Musi,et al.  Cellular Senescence in Idiopathic Pulmonary Fibrosis , 2021, Current Molecular Biology Reports.

[8]  T. Maher,et al.  Enhanced IL-1β Release Following NLRP3 and AIM2 Inflammasome Stimulation Is Linked to mtROS in Airway Macrophages in Pulmonary Fibrosis , 2021, Frontiers in Immunology.

[9]  J. Cortijo,et al.  Role of JAK/STAT in Interstitial Lung Diseases; Molecular and Cellular Mechanisms , 2021, International journal of molecular sciences.

[10]  P. Reynolds,et al.  A Role for RAGE in DNA Double Strand Breaks (DSBs) Detected in Pathological Placentas and Trophoblast Cells , 2021, Cells.

[11]  E. Kalkhoven,et al.  PPARgamma in Metabolism, Immunity, and Cancer: Unified and Diverse Mechanisms of Action , 2021, Frontiers in Endocrinology.

[12]  Anushya Muruganujan,et al.  The Gene Ontology resource: enriching a GOld mine , 2020, Nucleic Acids Res..

[13]  Minoru Kanehisa,et al.  KEGG: integrating viruses and cellular organisms , 2020, Nucleic Acids Res..

[14]  M. Oggioni,et al.  -->The CCL2/CCL7/CCL12/CCR2 pathway is substantially and persistently upregulated in mice after traumatic brain injury, and CCL2 modulates the complement system in microglia. , 2020, Molecular and cellular probes.

[15]  V. Boussiotis,et al.  The role of Peroxisome Proliferator-Activated Receptors (PPAR) in immune responses. , 2020, Metabolism: clinical and experimental.

[16]  S. Bydlowski,et al.  Cell Cycle Changes, DNA Ploidy, and PTTG1 Gene Expression in HTLV-1 Patients , 2020, Frontiers in Microbiology.

[17]  P. Spiegler,et al.  Idiopathic pulmonary fibrosis: Molecular mechanisms and potential treatment approaches. , 2020, Respiratory investigation.

[18]  C. Yao,et al.  Alveolar Epithelial Type II Cells as Drivers of Lung Fibrosis in Idiopathic Pulmonary Fibrosis , 2020, International journal of molecular sciences.

[19]  D. Tweardy,et al.  Targeting Janus Kinases and Signal Transducer and Activator of Transcription 3 To Treat Inflammation, Fibrosis, and Cancer: Rationale, Progress, and Caution , 2020, Pharmacological Reviews.

[20]  R. Gropler,et al.  Chemokine receptor 2-targeted molecular imaging in pulmonary fibrosis , 2020, bioRxiv.

[21]  Hans C. Bernstein,et al.  Systems biology: current status and challenges , 2020, Cellular and Molecular Life Sciences.

[22]  Ya Miao,et al.  Upregulation of flavin-containing monooxygenase 3 mimics calorie restriction to retard liver aging by inducing autophagy , 2020, Aging.

[23]  R. Zemans,et al.  Diverse Injury Pathways Induce Alveolar Epithelial Cell CCL2/12 Which Promotes Lung Fibrosis. , 2020, American journal of respiratory cell and molecular biology.

[24]  P. Barnes,et al.  Cellular Senescence as a Mechanism and Target in Chronic Lung Diseases. , 2019, American journal of respiratory and critical care medicine.

[25]  R. Bayliss,et al.  Mitotic phosphorylation by NEK6 and NEK7 reduces the microtubule affinity of EML4 to promote chromosome congression , 2019, Science Signaling.

[26]  M. Schuliga,et al.  STAT3 Regulates the Onset of Oxidant-Induced Senescence in Lung Fibroblasts. , 2019, American journal of respiratory cell and molecular biology.

[27]  E. Yeo.  Hypoxia and aging , 2019, Experimental & Molecular Medicine.

[28]  V. Thannickal,et al.  The Aging Lung and Idiopathic Pulmonary Fibrosis. , 2019, The American journal of the medical sciences.

[29]  G. Ferbeyre,et al.  The senescence-associated secretory phenotype and its regulation. , 2019, Cytokine.

[30]  Yuquan Wei,et al.  Targeting PI3K in cancer: mechanisms and advances in clinical trials , 2019, Molecular Cancer.

[31]  J. Escrivá,et al.  The JAK2 pathway is activated in idiopathic pulmonary fibrosis , 2018, Respiratory Research.

[32]  John Hardy,et al.  Genome, transcriptome and proteome: the rise of omics data and their integration in biomedical sciences , 2016, Briefings Bioinform..

[33]  Y. Kanwar,et al.  Contribution of myo-inositol oxygenase in AGE:RAGE-mediated renal tubulointerstitial injury in the context of diabetic nephropathy. , 2018, American journal of physiology. Renal physiology.

[34]  A. Schmidt,et al.  The AGE-RAGE Axis: Implications for Age-Associated Arterial Diseases , 2017, Front. Genet..

[35]  H. Hammes,et al.  Homeostatic nuclear RAGE–ATM interaction is essential for efficient DNA repair , 2017, Nucleic acids research.

[36]  Wing Hung Wong,et al.  Gaining comprehensive biological insight into the transcriptome by performing a broad-spectrum RNA-seq analysis , 2017, Nature Communications.

[37]  Matt Kaeberlein,et al.  Flavin-containing monooxygenases in aging and disease: Emerging roles for ancient enzymes , 2017, The Journal of Biological Chemistry.

[38]  A. Oberg,et al.  Cellular senescence mediates fibrotic pulmonary disease , 2017, Nature Communications.

[39]  Athol U. Wells,et al.  Idiopathic pulmonary fibrosis , 2012, Nature Reviews Disease Primers.

[40]  C. Garrido,et al.  Pleural inhibition of the caspase-1/IL-1β pathway diminishes profibrotic lung toxicity of bleomycin , 2016, Respiratory Research.

[41]  M. Molina-Molina,et al.  Increased AGE-RAGE ratio in idiopathic pulmonary fibrosis , 2016, Respiratory Research.

[42]  O. Eickelberg,et al.  Immune Mechanisms in Pulmonary Fibrosis. , 2016, American journal of respiratory cell and molecular biology.

[43]  Anuh T. George,et al.  STAT‐3 contributes to pulmonary fibrosis through epithelial injury and fibroblast‐myofibroblast differentiation , 2016, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[44]  J. Stewart,et al.  Molecular mechanisms of AGE/RAGE-mediated fibrosis in the diabetic heart. , 2014, World journal of diabetes.

[45]  W. Huber,et al.  Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 , 2014, Genome Biology.

[46]  V. Thannickal,et al.  Reversal of Persistent Fibrosis in Aging by Targeting Nox4-Nrf2 Redox Imbalance , 2014, Science Translational Medicine.

[47]  M. Narita,et al.  Cellular senescence and its effector programs , 2014, Genes & development.

[48]  S. Rosselot.  Idiopathic pulmonary fibrosis. , 2014, Nursing standard (Royal College of Nursing (Great Britain) : 1987).

[49]  J. Lupski,et al.  Human genome sequencing in health and disease. , 2012, Annual review of medicine.

[50]  D. Cleveland,et al.  The deubiquitinase USP44 is a tumor suppressor that protects against chromosome missegregation. , 2012, The Journal of clinical investigation.

[51]  N. Hay,et al.  PI3K-AKT-FoxO axis in cancer and aging. , 2011, Biochimica et biophysica acta.

[52]  Melissa G. Piper,et al.  Thrombospondin-1-deficient mice are not protected from bleomycin-induced pulmonary fibrosis. , 2011, American journal of respiratory cell and molecular biology.

[53]  G. M. Guglielmo.  TSP-1 in lung fibrosis , 2010, Journal of Cell Communication and Signaling.

[54]  Arnoud Sonnenberg,et al.  Integrin–TGF‐β crosstalk in fibrosis, cancer and wound healing , 2010, EMBO reports.

[55]  S. Rennard,et al.  The CC chemokine ligand 2 (CCL2) mediates fibroblast survival through IL-6. , 2007, American journal of respiratory cell and molecular biology.

[56]  P. Lansdorp,et al.  Telomerase mutations in families with idiopathic pulmonary fibrosis. , 2007, The New England journal of medicine.

[57]  C. Agostini,et al.  Chemokine/cytokine cocktail in idiopathic pulmonary fibrosis. , 2006, Proceedings of the American Thoracic Society.

[58]  L. Murray,et al.  The role of CCL12 in the recruitment of fibrocytes and lung fibrosis. , 2006, American journal of respiratory cell and molecular biology.

[59]  Timothy B. Stockwell,et al.  The Sequence of the Human Genome , 2001, Science.

[60]  M. Ashburner,et al.  Gene Ontology: tool for the unification of biology , 2000, Nature Genetics.

[61]  N. Kaminski,et al.  The integrin alpha v beta 6 binds and activates latent TGF beta 1: a mechanism for regulating pulmonary inflammation and fibrosis. , 1999, Cell.

[62]  N. Kaminski,et al.  A Mechanism for Regulating Pulmonary Inflammation and Fibrosis: The Integrin αvβ6 Binds and Activates Latent TGF β1 , 1999, Cell.

[63]  D. Mccormick.  Sequence the Human Genome , 1986, Bio/Technology.